10-Q
Quarterly Report
AMERICAN HEALTHCARE REIT, INC.
AHR
NYSE
CIK: 1632970
File #: 001-41951
Balance Sheet
54 line items · 2 periods
XBRL
| Item | Jun 30, 2025 | Dec 31, 2024 |
|---|---|---|
ASSETS | ||
Real estate investments, net | 3,346,121,000 | 3,366,648,000 |
United States | 3,301,363,000 | 3,324,982,000 |
International | 44,758,000 | 41,666,000 |
Debt security investment, net | 91,849,000 | 91,264,000 |
Cash and cash equivalents | 133,494,000 | 76,702,000 |
Restricted cash | 36,497,000 | 46,599,000 |
Accounts and other receivables, net | 224,072,000 | 211,104,000 |
Identified intangible assets, net | 155,886,000 | 161,473,000 |
Goodwill | 234,942,000 | 234,942,000 |
ISHC | 168,177,000 | 168,177,000 |
OM | 47,812,000 | 47,812,000 |
Triple-net leased properties | 18,953,000 | 18,953,000 |
Operating lease right-of-use assets, net | 147,893,000 | 163,987,000 |
2025 Acquisitions | 6,374,000 | — |
Other assets, net | 135,896,000 | 135,338,000 |
Total assets | 4,506,650,000 | 4,488,057,000 |
ISHC | 2,217,073,000 | 2,202,582,000 |
OM | 1,066,612,000 | 1,140,785,000 |
SHOP | 777,825,000 | 729,466,000 |
Triple-net leased properties | 402,703,000 | 401,782,000 |
Other | 42,437,000 | 13,442,000 |
LIABILITIES, REDEEMABLE NONCONTROLLING INTEREST AND EQUITY | ||
Liabilities: | ||
Mortgage loans payable, net | 983,510,000 | 982,071,000 |
Lines of credit and term loan, net | 549,632,000 | 688,534,000 |
Line of Credit - 2024 Credit Agreement | 550,000,000 | 689,000,000 |
Revolving Credit Facility - 2019 Trilogy Credit Facility | — | 32,000 |
Accounts payable and accrued liabilities | 273,702,000 | 258,324,000 |
Identified intangible liabilities, net | 2,618,000 | 3,001,000 |
Below-Market Lease | 2,618,000 | 3,001,000 |
Financing obligations | 34,364,000 | 34,870,000 |
Operating lease liabilities | 148,215,000 | 165,239,000 |
2025 Acquisitions | 7,445,000 | — |
Security deposits, prepaid rent and other liabilities | 51,965,000 | 51,856,000 |
Total liabilities | 2,044,006,000 | 2,183,895,000 |
Redeemable noncontrolling interests | 0 | 220,000 |
Equity: | ||
Stockholders’ equity: | ||
Preferred Stock | 0 | 0 |
Common Stock | 1,638,000 | 1,564,000 |
Additional paid-in capital | 3,957,653,000 | 3,720,268,000 |
Accumulated deficit | (1,536,301,000) | (1,458,089,000) |
Accumulated other comprehensive loss | (1,993,000) | (2,512,000) |
Total stockholders’ equity | 2,420,997,000 | 2,261,231,000 |
Noncontrolling interests | 41,647,000 | 42,711,000 |
Total equity | 2,462,644,000 | 2,303,942,000 |
Common Stock - Common Stock | 1,638,000 | 1,564,000 |
Additional Paid-In Capital | 3,957,653,000 | 3,720,268,000 |
Accumulated Deficit | (1,536,301,000) | (1,458,089,000) |
Accumulated Other Comprehensive Loss | (1,993,000) | (2,512,000) |
Total Stockholders' Equity | 2,420,997,000 | 2,261,231,000 |
Noncontrolling Interests | 41,647,000 | 42,711,000 |
Total liabilities, redeemable noncontrolling interests and equity | 4,506,650,000 | 4,488,057,000 |